Abbott Laboratories (ABT)
108.33
-0.46
(-0.42%)
USD |
NYSE |
Sep 04, 16:00
108.50
+0.17
(+0.16%)
Pre-Market: 20:00
Abbott Laboratories Research and Development Expense (Quarterly) : 892.00M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 892.00M |
| March 31, 2026 | 767.00M |
| December 31, 2025 | 721.00M |
| September 30, 2025 | 748.00M |
| June 30, 2025 | 718.00M |
| March 31, 2025 | 703.00M |
| December 31, 2024 | 728.00M |
| September 30, 2024 | 713.00M |
| June 30, 2024 | 697.00M |
| March 31, 2024 | 683.00M |
| December 31, 2023 | 690.00M |
| September 30, 2023 | 661.00M |
| June 30, 2023 | 710.00M |
| March 31, 2023 | 654.00M |
| December 31, 2022 | 691.00M |
| September 30, 2022 | 780.00M |
| June 30, 2022 | 684.00M |
| March 31, 2022 | 697.00M |
| December 31, 2021 | 758.00M |
| September 30, 2021 | 672.00M |
| June 30, 2021 | 654.00M |
| March 31, 2021 | 654.00M |
| December 31, 2020 | 698.00M |
| September 30, 2020 | 580.00M |
| June 30, 2020 | 564.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 576.00M |
| December 31, 2019 | 575.00M |
| September 30, 2019 | 594.00M |
| June 30, 2019 | 577.00M |
| March 31, 2019 | 670.00M |
| December 31, 2018 | 561.00M |
| September 30, 2018 | 573.00M |
| June 30, 2018 | 573.00M |
| March 31, 2018 | 581.00M |
| December 31, 2017 | 618.00M |
| September 30, 2017 | 493.00M |
| June 30, 2017 | 520.00M |
| March 31, 2017 | 541.00M |
| December 31, 2016 | 338.00M |
| September 30, 2016 | 336.00M |
| June 30, 2016 | 348.00M |
| March 31, 2016 | 336.00M |
| December 31, 2015 | 373.00M |
| September 30, 2015 | 340.00M |
| June 30, 2015 | 343.00M |
| March 31, 2015 | 313.00M |
| December 31, 2014 | 345.00M |
| September 30, 2014 | 305.00M |
| June 30, 2014 | 335.00M |
| March 31, 2014 | 346.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 258.00M |
| Boston Scientific Corp. | 554.00M |
| DexCom, Inc. | 153.00M |
| Insulet Corp. | 88.10M |
| Intuitive Surgical, Inc. | 370.40M |